AffyImmune Therapeutics
AffyImmune Therapeutics is a clinical-stage biotechnology company focusing on the optimization of CAR T cells for the treatment of solid tumors using thier Tune & Track platform.
1
Funding Rounds
$30.0m
Money raised
Overview
AffyImmune Therapeutics is a clinical-stage biotechnology company focusing on the optimization of CAR T cells for the treatment of solid tumors using thier Tune & Track platform.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ga** So** |
|
- | |
| Mo***** Ji* | - | - |
Funding series
Funding Series Analysis
The company AffyImmune Therapeutics has raised a total of $30m in funding over 1 rounds.
Key Insights:
- AffyImmunee Therapeutics Series A+ round, October 2021: $30m
AffyImmunee Therapeutics Series A+ round, October 2021
$30m
Industries
AffyImmune Therapeutics is active in the following industries: